| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +19% |
| 3Y CAGR | -2% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -80% |
| 3Y CAGR | -38% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,502.50 +45.30 (1.84%) | 19,010.91 | 28.04 | 5.64 | ||
PfizerPFIZER | ₹3,917.90 +14.10 (0.36%) | 17,930.59 | 20.86 | 4.09 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,514.50 +35.00 (0.54%) | 16,280.50 | 91.61 | 18.52 | ||
Natco PharmaNATCOPHARM | ₹804.35 -0.70 (0.09%) | 15,772.88 | 13.78 | 1.5 |